Hanyang Med Rev.  2014 Feb;34(1):2-3. 10.7599/hmr.2014.34.1.2.

Recent Progress in Non-Small Cell Lung Cancer: Prime Time for Personalized Therapy

• Ahn MJ

• KMID: 2168305
• DOI: http://doi.org/10.7599/hmr.2014.34.1.2

Abstract

No abstract available.

MeSH Terms

Carcinoma, Non-Small-Cell Lung*
Humans

Reference

1. Choi JH. Molecular biology of non-small-cell lung cancer. Hanyang Med Rev. 2014; 34:4–9.

2. Chung JH. Current issues in lung cancer pathology. Hanyang Med Rev. 2014; 34:10–14.

3. Won YW. Lung cancer screening. Hanyang Med Rev. 2014; 34:15–19.

4. Um SW. The role of endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) in the diagnosis and staging of lung cancer. Hanyang Med Rev. 2014; 34:20–25.

5. Cho JH, Choi YS. Minimally invasive thoracic surgery in lung cancer operation. Hanyang Med Rev. 2014; 34:26–30.

6. Park BB. Chemotherapy for non-small cell lung cancer. Hanyang Med Rev. 2014; 34:31–36.

7. Ahn MJ. Molecular targeted therapy in lung cancer. Hanyang Med Rev. 2014; 34:37–44.

8. Ahn YC. Role of radiation therapy for non-small cell lung cancer: focused on stereotactic ablative radiation therapy in early stage. Hanyang Med Rev. 2014; 34:45–50.